Nutcracker Therapeutics raises $167 Million in series C financing to advance its mRNA therapeutics and first-of-its-kind biochip-based manufacturing platform
Financing round led by returning investor ARCH Venture PartnersEnables accelerated development of therapeutic pipeline built upon its proprietary…
